Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 promote the transendothelial transport of High-Density Lipoprotein

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system

    Research output: Contribution to journalReviewResearchpeer-review

  2. Increased plasma apoM levels impair triglyceride turnover in mice

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Oral pre‑treatment with thiocyanate (SCN−) protects against myocardial ischaemia–reperfusion injury in rats

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Apolipoprotein M - a marker or an active player in type II diabetes?

    Research output: Contribution to journalReviewResearchpeer-review

  • Srividya Velagapudi
  • Lucia Rohrer
  • Francesco Poti
  • Renate Feuerborn
  • Damir Perisa
  • Dongdong Wang
  • Grigorios Panteloglou
  • Anton Potapenko
  • Mustafa Yalcinkaya
  • Andreas J Hülsmeier
  • Bettina Hesse
  • Alexander Lukasz
  • Mingxia Liu
  • John S Parks
  • Christina Christoffersen
  • Markus Stoffel
  • Manuela Simoni
  • Jerzy-Roch Nofer
  • Arnold von Eckardstein
View graph of relations

Objective: ApoM enriches S1P (sphingosine-1-phosphate) within HDL (high-density lipoproteins) and facilitates the activation of the S1P1 (S1P receptor type 1) by S1P, thereby preserving endothelial barrier function. Many protective functions exerted by HDL in extravascular tissues raise the question of how S1P regulates transendothelial HDL transport. Approach and Results: HDL were isolated from plasma of wild-type mice, Apom knockout mice, human apoM transgenic mice or humans and radioiodinated to trace its binding, association, and transport by bovine or human aortic endothelial cells. We also compared the transport of fluorescently-labeled HDL or Evans Blue, which labels albumin, from the tail vein into the peritoneal cavity of apoE-haploinsufficient mice with (apoE-haploinsufficient mice with endothelium-specific knockin of S1P1) or without (control mice, ie, apoE-haploinsufficient mice without endothelium-specific knockin of S1P1) endothelium-specific knockin of S1P1. The binding, association, and transport of HDL from Apom knockout mice and human apoM-depleted HDL by bovine aortic endothelial cells was significantly lower than that of HDL from wild-type mice and human apoM-containing HDL, respectively. The binding, uptake, and transport of 125I-HDL by human aortic endothelial cells was increased by an S1P1 agonist but decreased by an S1P1 inhibitor. Silencing of SR-BI (scavenger receptor BI) abrogated the stimulation of 125I-HDL transport by the S1P1 agonist. Compared with control mice, that is, apoE-haploinsufficient mice without endothelium-specific knockin of S1P1, apoE-haploinsufficient mice with endothelium-specific knockin of S1P1 showed decreased transport of Evans Blue but increased transport of HDL from blood into the peritoneal cavity and SR-BI expression in the aortal endothelium. Conclusions: ApoM and S1P1 promote transendothelial HDL transport. Their opposite effect on transendothelial transport of albumin and HDL indicates that HDL passes endothelial barriers by specific mechanisms rather than passive filtration.

Original languageEnglish
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume41
Issue number10
Pages (from-to)e468-e479
Number of pages11
ISSN1079-5642
DOIs
Publication statusPublished - Oct 2021

ID: 67686157